review Open AccessTop 10% cited
TLR-based immune adjuvants
Vaccine · 2010 · Vol. 29(17) · pp. 3341–3355
Folkert Steinhagen✉(National Cancer Institute)Takeshi Kinjo(National Cancer Institute)Christian Bode(National Cancer Institute)Dennis M. Klinman(National Cancer Institute)
Immune Response and InflammationImmunotherapy and Immune ResponsesPneumonia and Respiratory InfectionsVaccine adjuvantImmune systemToll-like receptorTollAdjuvantImmunologyMedicineBiologyComputational biologyInnate immune system
MeSH terms
Adjuvants, ImmunologicHumansVaccinationVaccinesToll-Like Receptors
Citations
497
FWCI
7.32
field-weighted impact
References
274
Percentile
98%
vs. same field & year
Citations per year
References
Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cells
European Journal of Immunology · 2001 · 872 citations
Pathogen Recognition and Innate Immunity
Cell · 2006 · 11,743 citations
Toll-like receptors and innate immunity
Biochemical and Biophysical Research Communications · 2009 · 1,162 citations
Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only
Vaccine · 2006 · 496 citations
Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities
European Journal of Immunology · 2003 · 589 citations
Tissue Expression of Human Toll-Like Receptors and Differential Regulation of Toll-Like Receptor mRNAs in Leukocytes in Response to Microbes, Their Products, and Cytokines
The Journal of Immunology · 2002 · 1,237 citations
CpG Motifs in Bacterial DNA and Their Immune Effects
Annual Review of Immunology · 2002 · 2,550 citations
Innate Immune Recognition
Annual Review of Immunology · 2002 · 8,305 citations
Related articles
Vaccine adjuvants revisited
Vaccine · 2007 · 492 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.